Skip to main content
. Author manuscript; available in PMC: 2010 Sep 30.
Published in final edited form as: Adv Drug Deliv Rev. 2009 Jul 20;61(11):940–952. doi: 10.1016/j.addr.2009.07.002

Figure 2.

Figure 2

Peptide-mediated targeting via ligand/cell-surface interactions. These strategies use ligands grafted onto the carrier/drug surface to increase the intracellular uptake of drug in target tissues (Table 2). A ligand is presented by the carrier, which binds to a moiety on the cellular surface, like specific receptors or nonspecific proteoglycans [141]. Surface binding may be followed by internalization through receptor-mediated endocytosis or other uptake mechanisms. Once internalized, the carrier or drug may be further processed via other cellular factors, such as pH or enzymatic activity.